In conclusion, this study shows that praziquantel can ameliorate BLM-induced pulmonary fibrosis in mice by affecting the balance of M2/M1 macrophages and suppressing the expression of TGF-β and MMP-12. The gene discussed is MMP12; the disease is pulmonary fibrosis.